| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-2478(00)00243-1 |
| P698 | PubMed publication ID | 10996622 |
| P50 | author | Jacques Banchereau | Q55097670 |
| P2093 | author name string | Palucka K | |
| Fay J | |||
| Nouri-Shirazi M | |||
| P2860 | cites work | Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain | Q24602799 |
| In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas | Q24652833 | ||
| Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
| Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells | Q24676842 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Dendritic cells in the T-cell areas of lymphoid organs | Q28239995 | ||
| Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset | Q28290931 | ||
| Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
| Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses | Q28616569 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
| Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
| The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Dendritic cell vaccines for cancer immunotherapy | Q33540299 | ||
| Dendritic cells. | Q33653670 | ||
| The makings of a tumor rejection antigen | Q33748013 | ||
| From synapses to immunological memory: the role of sustained T cell stimulation | Q33840553 | ||
| Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 | ||
| Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells | Q34029001 | ||
| Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
| Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. | Q34317099 | ||
| Distinct dendritic cell subsets differentially regulate the class of immune response in vivo | Q34950113 | ||
| Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo | Q36262520 | ||
| Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma | Q36356458 | ||
| Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes | Q36365159 | ||
| Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity | Q36366051 | ||
| Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines | Q36366108 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
| Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo | Q36367135 | ||
| Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny | Q36367357 | ||
| Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
| CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo | Q36367705 | ||
| The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli | Q36368355 | ||
| Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
| Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors | Q36380683 | ||
| Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases | Q36380718 | ||
| Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity | Q36380749 | ||
| Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
| Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis | Q36401257 | ||
| CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice | Q36401263 | ||
| Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin | Q36822416 | ||
| Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells | Q37396123 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| Developmental regulation of MHC class II transport in mouse dendritic cells. | Q41093187 | ||
| Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines | Q41415648 | ||
| The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
| Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells | Q46578425 | ||
| Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. | Q47872621 | ||
| Tumor-specific killer cells in paraneoplastic cerebellar degeneration | Q48353734 | ||
| Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. | Q50335820 | ||
| The linkage between T-cell and dendritic cell development in the mouse thymus. | Q52181534 | ||
| Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. | Q52192219 | ||
| Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. | Q54212663 | ||
| Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids | Q56765704 | ||
| Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon | Q57275922 | ||
| Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
| Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population | Q59056890 | ||
| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
| Effect of interleukin-10 on dendritic cell maturation and function | Q73396250 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q73672017 | ||
| Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma | Q73850975 | ||
| Dendritic cell-based immunotherapy of prostate cancer | Q74006769 | ||
| Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
| Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
| Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4 | Q77178595 | ||
| Tumor immunology: the glass is half full | Q77769105 | ||
| Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA | Q77849632 | ||
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 5-10 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | immunology Letters | Q15766068 |
| P1476 | title | Dendritic cell based tumor vaccines | |
| P478 | volume | 74 |
| Q35614635 | ALK a novel lymphoma-associated tumor antigen for vaccination strategies |
| Q37189574 | An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells |
| Q40008171 | Anti-tumor immunostimulatory effect of heat-killed tumor cells |
| Q33393205 | Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo |
| Q57158513 | Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL |
| Q33864097 | CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo |
| Q40762112 | Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA. |
| Q37777666 | Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system |
| Q35114583 | Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies |
| Q35922426 | Dendritic cell-based immunotherapy of malignant gliomas |
| Q45722523 | Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12. |
| Q45418280 | Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo |
| Q34386066 | Dendritic cells: their significance in health and disease |
| Q73520517 | Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes |
| Q33688447 | Effects of herpes simplex virus amplicon transduction on murine dendritic cells |
| Q73390645 | Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy |
| Q28347771 | Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide |
| Q33984920 | Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone. |
| Q39026704 | High hydrostatic pressure induces immunogenic cell death in human tumor cells |
| Q57295207 | Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease |
| Q34557611 | Immunotherapy for lung cancers |
| Q40616709 | In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses |
| Q40008890 | In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency |
| Q43874189 | In vivo imaging of lymph node migration of MNP- and (111)In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras). |
| Q54515978 | MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood. |
| Q37009032 | Medical management of pancreatic neuroendocrine tumors |
| Q37745683 | Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy. |
| Q40464391 | Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses. |
| Q36228550 | Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer |
| Q40427880 | Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials |
| Q37357300 | RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells |
| Q73507070 | Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity |
| Q92243921 | STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis |
| Q40016708 | Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35. |
| Q34740663 | Targeting epidermal Langerhans cells by epidermal powder immunization |
| Q34588561 | Targeting vaccines to dendritic cells |
| Q39814228 | Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo |
| Q44911093 | Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas |
Search more.